PMX-30063: Phase Ib data

Data from all 3 segments of a placebo-controlled, multiple-ascending dose Phase Ib trial in 77 healthy volunteers showed that 5-10 doses of 0.08-0.6 mg/kg/day PMX-30063 administered as a single infusi...